Where
EICC – The Exchange - Pentland, Level 3150 Morrison St
Pentland, Level 3
Edinburgh EH3 8EE
United Kingdom
Driving Directions
Contact
Adaptive Biotechnologies, Inc.Adaptive Biotechnologies, Inc.
858-775-5989
Treatment of CLL and the Value of Testing for Minimal Residual Disease (MRD)
The goal of this activity is to improve knowledge of clinical trial data and best practices on the use of minimal residual disease (MRD) measurement in the management of patients with CLL.
Registration is closed.
Go back to Event Page
Go back to Event Page